Thin Endometrium and IVF: Why Lining Thickness Matters

The uterine lining — the endometrium — is where an embryo must implant to establish a pregnancy. For implantation to succeed, the endometrium needs to be not just present, but adequately developed — the right thickness, the right texture, and in the right phase of development relative to the stage of the embryo being transferred.

Thin endometrium is a recognised cause of IVF failure and is found in a small but significant proportion of women undergoing fertility treatment. Understanding why it occurs, how it is diagnosed, and what treatment options exist is particularly important for women who have experienced unexplained implantation failure despite good embryo quality.

What Is the Normal Endometrial Thickness for IVF?

Endometrial thickness is measured by transvaginal ultrasound on the day of embryo transfer (or in the days preceding it). The measurement is taken at the widest point of the endometrium, spanning both layers, in a sagittal plane.

Clinical thresholds used in IVF practice:

• Ideal: 8 to 14 mm — the range associated with the highest implantation rates
• Acceptable: 7 to 8 mm — implantation is possible but rates are modestly reduced
• Borderline: 6 to 7 mm — implantation rates are significantly reduced; many clinicians recommend deferring transfer
• Thin: Below 6 mm — associated with very low implantation rates; transfer is generally not recommended without further treatment

Pattern also matters. A trilaminar (triple-layer) appearance on ultrasound — representing the organized proliferative endometrium — is associated with better implantation outcomes than a homogeneous or echogenic pattern at the same thickness.

What Causes Thin Endometrium?

• Asherman's syndrome (intrauterine adhesions): Scarring of the endometrium from previous uterine surgery — particularly repeated D&C procedures, postpartum curettage, or traumatic myomectomy. Dense adhesions reduce the functional endometrial surface and prevent adequate development.
• Inadequate oestrogen response: Oestrogen drives endometrial proliferation. Women who produce insufficient oestrogen, or whose endometrium does not respond normally to oestrogen, may not develop adequate thickness despite appropriate hormone dosing.
• Reduced uterine blood flow: Impaired blood supply to the uterus — from previous surgery, radiation, or vascular factors — limits endometrial development.
• Chronic endometritis: Subclinical infection or inflammation of the endometrial lining, detectable on hysteroscopy or by specialist endometrial biopsy, can impair development and receptivity.
• Previous radiotherapy to the pelvis: Can permanently damage the endometrial stem cell population, resulting in irreversible thinning.

Diagnosing the Cause of Thin Endometrium

Before planning treatment for thin endometrium, identifying the underlying cause is essential:

• Hysteroscopy: Direct visualisation of the uterine cavity to assess for adhesions, poor vascularisation, or chronic endometritis findings
• Endometrial biopsy for CD138 testing: Identifies plasma cells diagnostic of chronic endometritis — treated with targeted antibiotics
• Doppler blood flow assessment: Uterine artery Doppler during endometrial preparation assesses blood flow; poor flow correlates with poor response
• Serial oestrogen levels and endometrial thickness monitoring: To understand how the endometrium is responding to standard preparation protocols

Treatment Approaches for Thin Endometrium

Optimising Standard Preparation

The first step is ensuring the standard oestrogen preparation protocol is optimal — correct dose, route of administration (oral, transdermal, or injectable), and duration. For some women, switching from oral to transdermal oestrogen or increasing the dose improves response. The timing of progesterone addition relative to endometrial thickness is also important.

Sildenafil (Viagra)

Used as a vaginal preparation, sildenafil improves uterine blood flow by promoting local vasodilation. Several studies have demonstrated modest improvement in endometrial thickness in women with poor response to standard oestrogen. It is well-tolerated and widely used in the management of thin endometrium.

Low-Dose Aspirin

Aspirin (75 to 100 mg daily) promotes uterine blood flow through anti-platelet and vasodilatory mechanisms. Widely prescribed as an adjunct in thin endometrium management — though evidence from controlled trials is modest.

Hysteroscopic Adhesiolysis

For women with intrauterine adhesions causing thin endometrium, hysteroscopic lysis of adhesions — removing the scar tissue under direct visualisation — is the primary treatment. Outcomes depend on the severity of adhesions; mild to moderate Asherman's can be very successfully treated, while severe obliterative adhesions are much more challenging.

Intrauterine PRP (Platelet-Rich Plasma)

Intrauterine PRP infusion — instilling concentrated platelet-rich plasma from the patient's own blood into the uterine cavity — is an emerging treatment for refractory thin endometrium. Platelets release growth factors (VEGF, EGF, PDGF) that stimulate tissue proliferation and angiogenesis. Several studies have reported improvements in endometrial thickness and clinical pregnancy rates in women who failed to respond to standard treatment. Evidence from large randomised trials is still awaited, but the procedure is low-risk and a reasonable option in refractory cases.

Frequently Asked Questions

Q1. Should I cancel my IVF transfer if my lining is below 7mm?

This is a clinical judgment call that depends on the specific thickness, the embryo quality, the patient's history, and whether any further intervention can meaningfully improve the lining in time. Below 6 mm, most clinicians recommend deferring transfer. Between 6 and 7 mm, the decision is made case by case. Transferring into a persistently thin lining despite good embryo quality rarely results in pregnancy — and uses precious embryos.

Q2. Can thin endometrium be permanently cured?

It depends on the cause. Adhesiolysis for mild to moderate Asherman's often produces lasting improvement. Optimisation of oestrogen protocol may be a permanent solution for those who respond. Radiation-induced thin endometrium is more difficult to treat and may be permanent — in these cases, gestational surrogacy is sometimes discussed when the endometrium is truly irreparable. Most cases of thin endometrium respond to some degree to optimised management.

Q3. Does thin endometrium affect natural conception too?

Yes — a thin or poorly developed endometrium in natural cycles can impair implantation just as in IVF. However, natural cycle endometrial development involves a different hormonal sequence from IVF preparation, and some women who struggle to achieve adequate thickness on exogenous oestrogen develop better naturally. If this is the case, a natural cycle FET may be worth trying alongside investigations into the underlying cause.